171 related articles for article (PubMed ID: 26929400)
1. Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment.
Kharlamova AD; Lushchekina SV; Petrov KA; Kots ED; Nachon F; Villard-Wandhammer M; Zueva IV; Krejci E; Reznik VS; Zobov VV; Nikolsky EE; Masson P
Biochem J; 2016 May; 473(9):1225-36. PubMed ID: 26929400
[TBL] [Abstract][Full Text] [Related]
2. Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning.
Saifina LF; Abdalla M; Gubaidullina LM; Zueva IV; Eltayb WA; El-Arabey AA; Kharlamova AD; Lenina OA; Semenov VE; Petrov KA
Eur J Med Chem; 2023 Jan; 246():114949. PubMed ID: 36462442
[TBL] [Abstract][Full Text] [Related]
3. C-547, a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase: Pharmacokinetic and pharmacodynamic studies.
Petrov K; Zueva I; Kovyazina I; Sedov I; Lushchekina S; Kharlamova A; Lenina O; Koshkin S; Shtyrlin Y; Nikolsky E; Masson P
Neuropharmacology; 2018 Mar; 131():304-315. PubMed ID: 29277489
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling of mechanism of action of anti-myasthenia gravis slow-binding inhibitor of acetylcholinesterase.
Lushchekina S; Kots E; Kharlamova A; Petrov K; Masson P
Int J Risk Saf Med; 2015; 27 Suppl 1():S74-5. PubMed ID: 26639721
[TBL] [Abstract][Full Text] [Related]
5. New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease.
Zueva I; Dias J; Lushchekina S; Semenov V; Mukhamedyarov M; Pashirova T; Babaev V; Nachon F; Petrova N; Nurullin L; Zakharova L; Ilyin V; Masson P; Petrov K
Neuropharmacology; 2019 Sep; 155():131-141. PubMed ID: 31132435
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship of quaternary acetylcholinesterase inhibitors - outlook for early myasthenia gravis treatment.
Komloova M; Musilek K; Dolezal M; Gunn-Moore F; Kuca K
Curr Med Chem; 2010; 17(17):1810-24. PubMed ID: 20345342
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
Musilek K; Komloova M; Zavadova V; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K; Jung YS
Bioorg Med Chem Lett; 2010 Mar; 20(5):1763-6. PubMed ID: 20138518
[TBL] [Abstract][Full Text] [Related]
8. Macrocyclic derivatives of 6-methyluracil: New ligands of the peripheral anionic site of acetylcholinesterase.
Petrov K
Int J Risk Saf Med; 2015; 27 Suppl 1():S72-3. PubMed ID: 26639720
[TBL] [Abstract][Full Text] [Related]
9. Slow-binding inhibition of cholinesterases, pharmacological and toxicological relevance.
Masson P; Lushchekina SV
Arch Biochem Biophys; 2016 Mar; 593():60-8. PubMed ID: 26874196
[TBL] [Abstract][Full Text] [Related]
10. 1-(3-
Zueva IV; Lushchekina SV; Pottie IR; Darvesh S; Masson P
Biomolecules; 2020 Nov; 10(12):. PubMed ID: 33260981
[TBL] [Abstract][Full Text] [Related]
11. Slow-binding inhibitors of acetylcholinesterase of medical interest.
Lushchekina SV; Masson P
Neuropharmacology; 2020 Oct; 177():108236. PubMed ID: 32712274
[TBL] [Abstract][Full Text] [Related]
12. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
Komloova M; Musilek K; Horova A; Holas O; Dohnal V; Gunn-Moore F; Kuca K
Bioorg Med Chem Lett; 2011 Apr; 21(8):2505-9. PubMed ID: 21397501
[TBL] [Abstract][Full Text] [Related]
13. 6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.
Semenov VE; Zueva IV; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
ChemMedChem; 2015 Nov; 10(11):1863-74. PubMed ID: 26412714
[TBL] [Abstract][Full Text] [Related]
14. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
[TBL] [Abstract][Full Text] [Related]
15. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
[TBL] [Abstract][Full Text] [Related]
16. Inhibition pathways of the potent organophosphate CBDP with cholinesterases revealed by X-ray crystallographic snapshots and mass spectrometry.
Carletti E; Colletier JP; Schopfer LM; Santoni G; Masson P; Lockridge O; Nachon F; Weik M
Chem Res Toxicol; 2013 Feb; 26(2):280-9. PubMed ID: 23339663
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of cardiac muscle insensitivity to a novel acetylcholinesterase inhibitor C-547.
Abramochkin DV; Petrov KA; Zobov VV; Yagodina LO; Nikolsky EE; Rosenshtraukh LV
J Cardiovasc Pharmacol; 2009 Feb; 53(2):162-6. PubMed ID: 19188831
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study.
Rosenberry TL; Brazzolotto X; Macdonald IR; Wandhammer M; Trovaslet-Leroy M; Darvesh S; Nachon F
Molecules; 2017 Nov; 22(12):. PubMed ID: 29186056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
